Advanced Brain Monitoring

Focus: Advanced Brain Monitoring develops EEG headsets, physiological monitoring systems, and software focused on neurology applications. The company is a publicly-traded biotech firm founded in 2020 and headquartered in Carlsbad, CA.

Neurology

Profile data last refreshed 2d ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

About Advanced Brain Monitoring

AI assessmentNot Hiring

No open roles listed right now. Follow Advanced Brain Monitoring to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

4 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Cannabis

Driving Under the Influence

N/A

Clinical Trials (1)

NCT04230460Cannabis Impairment Detection Application (CIDA)

N/A

Help build intelligence for Advanced Brain Monitoring

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage public company (founded 2020) with potential upside if neurology monitoring platforms gain clinical traction
Diversified pipeline spanning cannabis detection, sleep apnea intervention, traumatic brain injury monitoring, and upper airway resistance—broad therapeutic reach within neurology
Hardware + software + monitoring approach represents differentiated technology platform vs. traditional pharma modalities

Watch Out For

No active FDA trials reported (zero Phase 1/2/3 programs), suggesting early preclinical or early clinical stage with uncertain timelines to regulatory catalysts
Zero active job openings at time of analysis indicates either early hiring freeze, recent consolidation, or minimal near-term growth plans
Limited public financial data, publications (0 recorded), and revenue information create visibility gaps on company trajectory and R&D intensity

Generated by Claude from Advanced Brain Monitoring's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Patient will wear ARES device while undergoing sleep study

Upper Airway Resistance Syndrome

N/A

Clinical Trials (1)

NCT00528749Non-Invasive Measurement of Respiratory Effort

N/A

Deliver therapy when the supine position is detected

Obstructive Sleep Apnea

N/A

Clinical Trials (1)

NCT02032706Validation of Safety and Efficacy for Night Shift Therapy

N/A

Noninvasive Monitoring of Cerebral Blood Flow Autoregulation in Patients With Traumatic Brain Injury

Traumatic Brain Injury (TBI)

N/A

Clinical Trials (1)

NCT01605838Noninvasive Monitoring of Cerebral Blood Flow Autoregulation in Patients With Traumatic Brain Injury (TBI)

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2020

Portfolio: 4 clinical trials

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo